[ Prev | Top | Next ]

Publication Date - 12/3/1999

18. NIH/NIDA - Drug Abuse Prevention Intervention Research

The National Institute on Drug Abuse (NIDA) invites Drug Abuse Prevention Intervention Research. This research applies theories and empirical findings on the biologic, genetic, psychological, social, and environmental origins of the onset and progression of drug abuse an addiction to the design, development, and testing of prevention strategies and interventions.

NIDA's prevention research program is designed to identify and test promising theory-based prevention practices, to examine program components that account for effectiveness, and to promote the adoption of effective prevention strategies. Primary goals of prevention intervention research are as follows:

• to design, develop, and test innovative, theory-based prevention strategies that build on research on the origins and pathways to drug abuse and addiction;
• to assess the effectiveness of efficacious strategies and interventions under less controlled "real-world" conditions;
• to determine what components of effective strategies and programs account for effectiveness and the processes involved in their success;
• to clarify organization, management, financing, delivery and other factors related to the effective and efficient provision of prevention services in the United States;
• to improve prevention research methodology to assess the complex process, outcomes, and systematic impacts of prevention services.

Additionally, the NIDA recognizes that there are multiple pathways to and patterns of drug abuse that may vary by geographic location, ethnicity, cultural group, lifestyle choices, gender, and individual differences. Thus, prevention research should focus attention on

• recognizing variations in community, ethnic, cultural, lifestyle, gender, and individual issues, concerns, and risk factors;
• developing strategies that address these sub-population differences;
• understanding the processes, mechanism, and reasons why some prevention components may be universally effective whereas other must be adapted for sub-groups.

The support mechanisms available for support of this program announcement (PA) are the NIH research project grants (RO1), small grants (RO3), exploratory/developmental grants (R21), program projects (PO1), and research centers (P30, P50, and P60). Modular grant application and award procedures will apply to all competing individual research project grants (RO1), small grants (RO3), and exploratory/developmental grants (R21) applications requesting up to $250,000 direct cost per year.

Applications are due at the NIH Center for Scientific Review on or before FEBRUARY 1, JUNE I, or OCTOBER 1, 2000.

[ Prev | Top | Next ]